FDA’s Risk/Benefit Decisions Will Be Quantified With Metric From Contractor

A recent request for proposals may signal a shift in FDA's approach to risk/benefit analysis and views on outcome measures, a move some see as bringing more transparency while also shielding the agency from criticism